Technical Analysis for FLDM - Fluidigm Corporation

Grade Last Price % Change Price Change
grade F 3.64 -5.45% -0.21
FLDM closed down 5.45 percent on Friday, June 5, 2020, on 87 percent of normal volume. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Up Down
Historical FLDM trend table...

Date Alert Name Type % Chg
Fell Below 200 DMA Bearish 0.00%
New Downtrend Bearish 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Wide Bands Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -5.45%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Fluidigm Corporation develops, manufactures, and markets microfluidic systems for academic research institutions, clinical laboratories, pharmaceutical companies, and biotechnology and Ag-Bio companies. Its proprietary microfluidic systems consist of instruments and consumables, including integrated fluidic circuits (IFCs), assays, and other reagents. The company's products include BioMark HD system that performs high-throughput gene expression analysis, single-cell gene expression analysis, single nucleotide polymorphism (SNP) genotyping, and digital polymerase chain reaction (PCR) using Fluidigm DELTAgene and SNPtype assays, other chemistries, and Fluidigm dynamic array and digital array IFCs; and EP1 system that performs SNP genotyping using Fluidigm SNPtype assays or TagMan assays, as well as end-point digital PCR using TaqMan assays, and Fluidigm Dynamic Array and Digital Array IFCs. Its products also comprise C1 Single-Cell Auto Prep system, which enables rapid and reliable isolation, processing, and profiling of individual cells for genomic analysis for various applications, such as targeted single-cell gene expression and single-cell messenger ribonucleic acids analysis; and Access Array system that enables automated sample preparation, barcoding, and tagging of targeted resequencing libraries. In addition, the company offers dynamic array, digital array, C1 single-cell auto prep array, and access array IFCs; and DELTAgene and SNPtype assays, and access array target-specific primers. Fluidigm Corporation distributes its systems through direct sales force and support organizations in North America, Europe, and the Asia-Pacific; and through distributors or sales agents in Europe, Latin America, the Middle East, and the Asia-Pacific countries. The company was formerly known as Mycometrix Corporation and changed its name to Fluidigm Corporation in April 2001. Fluidigm Corporation was founded in 1999 and is headquartered in South San Francisco, California.
Biotechnology Pharmaceutical Biology Natural Sciences Molecular Biology Gene Expression Laboratory Techniques Genotyping Polymerase Chain Reaction SNP

Is FLDM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 12.95
52 Week Low 1.17
Average Volume 2,014,972
200-Day Moving Average 3.67
50-Day Moving Average 3.29
20-Day Moving Average 4.56
10-Day Moving Average 4.36
Average True Range 0.49
ADX 27.79
+DI 20.02
-DI 21.49
Chandelier Exit (Long, 3 ATRs ) 4.26
Chandelier Exit (Short, 3 ATRs ) 4.99
Upper Bollinger Band 5.31
Lower Bollinger Band 3.81
Percent B (%b) -0.11
BandWidth 32.88
MACD Line 0.17
MACD Signal Line 0.36
MACD Histogram -0.1877
Fundamentals Value
Market Cap 107.07 Million
Num Shares 29.4 Million
EPS -2.45
Price-to-Earnings (P/E) Ratio -1.49
Price-to-Sales 1.81
Price-to-Book 7.30
PEG Ratio 0.38
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.41
Resistance 3 (R3) 4.49 4.31 4.28
Resistance 2 (R2) 4.31 4.12 4.27 4.23
Resistance 1 (R1) 3.98 4.00 3.89 3.90 4.19
Pivot Point 3.80 3.80 3.76 3.76 3.80
Support 1 (S1) 3.47 3.61 3.38 3.39 3.09
Support 2 (S2) 3.29 3.49 3.25 3.05
Support 3 (S3) 2.96 3.29 3.00
Support 4 (S4) 2.88